ViiV’s two-drug HIV therapy Dovato gets Japanese approvalOne of ViiV Healthcare’s two-drug HIV therapies – Dovato – has been approved in Japan, providing a new Share XViiV’s two-drug HIV therapy Dovato gets Japanese approvalhttps://pharmaphorum.com/news/viivs-two-drug-hiv-therapy-dovato-gets-japanese-approval/
ViiV files first-in-class HIV drug in EuropeViiV Healthcare has filed its new HIV drug fostemsavir for approval in Europe, a few weeks after the Share XViiV files first-in-class HIV drug in Europehttps://pharmaphorum.com/news/viiv-files-first-in-class-hiv-drug-in-europe/
FDA knocks back ViiV, J&J’s long-acting HIV regimenPeople with HIV hoping to be freed from daily doses of tablets will have to wait a little Share XFDA knocks back ViiV, J&J’s long-acting HIV regimenhttps://pharmaphorum.com/news/fda-knocks-back-viiv-jjs-long-acting-hiv-regimen/
ViiV presses go on FDA filing for first-in-class HIV drug fostemsavirViiV Healthcare has fulfilled its pledge of submitting its new HIV drug fostemsavir for approval before year end, Share XViiV presses go on FDA filing for first-in-class HIV drug fostemsavirhttps://pharmaphorum.com/news/viiv-presses-go-on-fda-filing-for-first-in-class-hiv-drug-fostemsavir/
ViiV files monthly HIV jab in EuropeViiV Healthcare has submitted its once-monthly two-drug injectable therapy for HIV to the EMA, setting up possible approval Share XViiV files monthly HIV jab in Europehttps://pharmaphorum.com/news/viiv-files-monthly-hiv-jab-in-europe/
ViiV’s first-in-class HIV drug on course for filings this yearViiV Healthcare has new data on its first-in-class HIV drug fostemsavir that back up its long-term effects, and Share XViiV’s first-in-class HIV drug on course for filings this yearhttps://pharmaphorum.com/news/viivs-first-in-class-hiv-drug-on-course-for-filings-this-year/
GSK’s monthly HIV treatment breakthroughGlaxoSmithKline has seen positive clinical results from the phase 3 study of its once-monthly injectable HIV treatment, stepping Share XGSK’s monthly HIV treatment breakthroughhttps://pharmaphorum.com/news/gsks-monthly-hiv-treatment-breakthrough/
ViiV prepares another two-drug HIV filingViiV Healthcare says it is on course to change standard care in HIV treatment by providing another combination Share XViiV prepares another two-drug HIV filinghttps://pharmaphorum.com/news/viiv-prepares-another-two-drug-hiv-filing/
Positive results announced for ViiV Healthcare’s two-drug HIV pillA two-drug strategy has shown positive results, giving new hope to patients with HIV. ViiV Healthcare, which is Share XPositive results announced for ViiV Healthcare’s two-drug HIV pillhttps://pharmaphorum.com/news/positive-results-hiv-pill/
